Immuneering (IMRX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 11, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by June 10, 2026.

Voting matters and shareholder proposals

• Election of two Class II directors: Peter Feinberg and Laurie B. Keating, with board recommendation to vote in favor.

• Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended by the board.

• Provision for other business to be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting for both nominated directors and the auditor ratification.